Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.

The pharmacokinetics of once-daily oral levofloxacin (study A) or intravenous levofloxacin (study B) in 40 healthy male volunteers were investigated in two separate randomized, double-blind, parallel-design, placebo-controlled studies. Levofloxacin at 500 mg or placebo was administered orally or int...

Полное описание

Библиографические подробности

Опубликовано в::	Antimicrob Agents Chemother
Главные авторы:	Chien, S C, Rogge, M C, Gisclon, L G, Curtin, C, Wong, F, Natarajan, J, Williams, R R, Fowler, C L, Cheung, W K, Chow, A T
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 1997
Предметы:	Research Article
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164102/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9333057/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.10.2256
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!